17 reports

  • 2.3 Symptoms
  • Gastric Cancer, Stage Grouping

It is also used when a patient presents certain risk factors for gastric cancer, such as genetic or familial factors (ACS, 2014).

  • Gastric Cancer
  • World
  • Market Size
  • AstraZeneca PLC
  • Roche Group

" Originally, targeted therapy' s mechanism was to target the key genetic abnormality.

  • Gastric Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

Gastric cancer

4546 5000 3864
  • INDIVIDUALS WITH A FAMILY HISTORY OF GASTRIC CANCER ARE AT GREATER RISK OF DEVELOPING THE DISEASE

The most important gastric cancer genetic susceptibility lies in inherited loss-of-function mutations of the tumor suppressor gene CDH##.

  • Gastric Cancer
  • Asia
  • Japan
  • Eli Lilly & Co.
  • Merck & Co., Inc.

" Originally, targeted therapy' s mechanism was to target the key genetic abnormality.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

" Originally, targeted therapy' s mechanism was to target the key genetic abnormality.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

" Originally, targeted therapy' s mechanism was to target the key genetic abnormality.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

" Originally, targeted therapy' s mechanism was to target the key genetic abnormality.

  • Gastric Cancer
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • T-001 - DRUG PROFILE
  • AMBRX INC

A key secondary endpoint of the FB-## trial was to evaluate molecular and genetic markers for correlation with response.

  • Gastric Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative

The institute' s outpatient services include immunization services, genetic counseling, donation of bodies to research, forensic medicine, and others.

  • Gastric Cancer
  • Therapy
  • Australia
  • M&A
  • Imugene Limited
  • 1.3 STAGES

Genetic syndromes inherited from a person' s parents such as hereditary are also known to cause gastric cancer.

  • Gastric Cancer
  • United States
  • World
  • Market Size
  • Merck & Co., Inc.
  • Target
  • 5. All the trials included are unique trials.

Genetic Polymorphisms of Drug Metabolism and Immunohistochemical Stain to Predict the Efficacy and Toxicity in Patients With Gastric Adenocarcinoma - A Phase II Study Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study GDCT## NCT##

  • Chemotherapy
  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • 5. All the trials included are unique trials.

Genetically Pre-screened Cancers With EGFR and/ or HER## Gene Amplification or EFGR Activating Mutations Phase II Trial of BIBW ## in Genetically Pre-screened Cancers With EGFR and/ or HER## Gene Amplification GDCT## NCT##, ##. ## Oncology Biliary Tumor, Esophag

  • Clinical Trial
  • Gastric Cancer
  • Lung Cancer
  • World
  • Product Initiative
  • T-001 - DRUG PROFILE
  • ADAPTIMMUNE THERAPEUTICS PLC

The clinical responses have been independent of high-risk clinical or genetic features.

  • Gastric Cancer
  • Monoclonal Antibody
  • North America
  • United States
  • Product Initiative
  • Clinical Trial profile. 1592 Trial Title
  • Clinical Trial Profile Snapshots

Genetic Polymorphism of Aldehyde Dehydrogenase ## (ALDH##) in Safety of Paclitaxel for the Patients with Alcohol Intolerance Pilot Study of Usefulness of Analysis of Genetic Polymorphism of Aldehyde Dehydrogenase ## (ALDH##) in Safety of Paclitaxel for the Patients with Alcohol Intoler

  • Clinical Trial
  • Gastric Cancer
  • Therapy
  • World
  • F. Hoffmann-La Roche Ltd.

Oryzon Genomics S. A.

  • Gastric Cancer
  • Genomics
  • Spain
  • Company
  • Oryzon Genomics S.A.
  • GASTRIC CANCER - PIPELINE BY ALTEOGEN INC
  • GASTRIC CANCER - PIPELINE BY MACROGENICS INC

TABLE ##: GASTRIC CANCER - PIPELINE BY ALTEOGEN INC AMBRX INC (AMBRX) IS A BIOPHARMACEUTICAL COMPANY WHICH FOCUSES ON THE DISCOVERY AND DEVELOPMENT OF PROTEIN-BASED MEDICINES BY USING ITS EXPANDED GENETIC CODE.

  • Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Pharmaceutical
  • Merck & Co., Inc.
  • Gastric Cancer, Tumor, Node and Metastasis
  • The Case for Innovation

Additionally, in genetically-driven indications, the rate of mutation of each first-in-class target is considered.

  • Cancer
  • Gastric Cancer
  • Pathology
  • Therapy